Sreeraj Gopi

Dr. Sreeraj Gopi

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Journal of Traditional and Complementary Medicine
Verified
Journal Article
Open access
AAAugustine Amalraj
Augustine Amalraj
APAnitha Pius
Anitha Pius
Sreerag GopiSreerag Gopi
Sreerag Gopi
SGSreeraj Gopi
Sreeraj Gopi
In recent years, several drugs have been developed deriving from traditional products and current drug research is actively investigating the possible therapeutic roles of many Ayruvedic and Traditional Indian medicinal therapies. Among those being investigated is Turmeric. Its most important active ingredient is curcuminoids. Curcuminoids are phenolic compounds commonly used as a spice, pigment and additive also utilized as a therapeutic agent used in several foods. Comprehensive research over the last century has revealed several important functions of curcuminoids. Various preclinical cell culture and animals studies suggest that curcuminoids have extensive biological activity as an antioxidant, neuroprotective, antitumor, anti-inflammatory, anti-acidogenic, radioprotective and arthritis. Different clinical trials also suggest a potential therapeutic role for curcuminoids in numerous chronic diseases such as colon cancer, lung cancer, breast cancer, inflammatory bowel diseases. The aim of this review is to summarize the chemistry, analog, metal complex, formulations of curcuminoids and their biological activities.

1 May 2020 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
AAAugustine Amalraj
Augustine Amalraj
Józef Tadeusz HaponiukJózef Tadeusz Haponiuk
Józef Tadeusz Haponiuk
STSabu Thomas
Sabu Thomas
SGSreeraj Gopi
Sreeraj Gopi

1 January 2017 in Journal of Traditional and Complementary Medicine
Verified
Journal Article
Open access
AAAugustine Amalraj
Augustine Amalraj
SGSreeraj Gopi
Sreeraj Gopi
Medicinal plants have been a main source of therapeutic agents from ancient time to cure diseases. Terminalia arjuna (Roxb.) Wight & Arn. (T. arjuna) is one of the most accepted and beneficial medicinal plants in indigenous system of medicine for the treatment of various critical diseases. This comprehensive review provides various aspects of its ethnomedical, phytochemical, pharmacognostical, pharmacological and clinical significance to different diseases particularly in cardiovascular conditions. This plant has a good safety outline when used in combination with other conventional drugs. This review highlights various medicinal properties of T. arjuna through different studies such as antioxidant, hypotensive, anti-atherogenic, anti-inflammatory, anti-carcinogenic, anti-mutagenic and gastro-productive effect.

1 October 2017 in Journal of Medicinal Food
Verified
Journal Article
Closed access
AAAugustine Amalraj
Augustine Amalraj
KVKarthik Varma
Karthik Varma
JJJoby Jacob
Joby Jacob
CDChandradhara Divya
Chandradhara Divya
AKAjaikumar B. Kunnumakkara
Ajaikumar B. Kunnumakkara
SGSreeraj Gopi
Sreeraj Gopi
Rheumatoid arthritis (RA) is an autoimmune, chronic systemic inflammatory disorder. The long-term use of currently available drugs for the treatment of RA has many potential side effects. Natural phytonutrients may serve as alternative strategies for the safe and effective treatment of RA, and curcuminoids have been used in Ayurvedic medicine for the treatment of inflammatory conditions for centuries. In this study, a novel, highly bioavailable form of curcumin in a completely natural turmeric matrix was evaluated for its ability to improve the clinical symptoms of RA. A randomized, double-blind, placebo-controlled, three-arm, parallel-group study was conducted to evaluate the comparative efficacy of two different doses of curcumin with that of a placebo in active RA patients. Twelve patients in each group received placebo, 250 or 500 mg of the curcumin product twice daily for 90 days. The responses of the patients were assessed using the American College of Rheumatology (ACR) response, visual analog scale (VAS), C-reactive protein (CRP), Disease Activity Score 28 (DAS28), erythrocyte sedimentation rate (ESR), and rheumatoid factor (RF) values. RA patients who received the curcumin product at both low and high doses reported statistically significant changes in their clinical symptoms at the end of the study. These observations were confirmed by significant changes in ESR, CPR, and RF values in patients receiving the study product compared to baseline and placebo. The results indicate that this novel curcumin in a turmeric matrix acts as an analgesic and anti-inflammatory agent for the management of RA at a dose as low as 250 mg twice daily as evidenced by significant improvement in the ESR, CRP, VAS, RF, DAS28, and ACR responses compared to placebo. Both doses of the study product were well tolerated and without side effects.

1 July 2017 in Journal of Traditional and Complementary Medicine
Verified
Journal Article
Open access
AAAugustine Amalraj
Augustine Amalraj
SGSreeraj Gopi
Sreeraj Gopi
Ferula asafoetida Linn. is a main source of asafoetida, a strong, tenacious and sulfurous odor, and oleo-gum resin of medicinal and nutritional importance. Asafoetida has been consumed as a spice and a folk medicine for centuries. Recent studies have shown several promising activities particularly relaxant, neuroprotective, memory enhancing, digestive enzyme, antioxidant, antispasmodic, hypotensive, hepatoprotective, antimicrobial, anticarcinogenic, anticancer, anticytotoxicity, antiobesity, anthelmintic and antagonistic effect. This review effectively deals with phytochemistry and various pharmacological and clinical studies of asafoetida.

13 October 2017 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
SGSreeraj Gopi
Sreeraj Gopi
JJJoby Jacob
Joby Jacob
KVKarthik Varma
Karthik Varma
SJShintu Jude
Shintu Jude
AAAugustine Amalraj
Augustine Amalraj
SSSidney Stohs
Sidney Stohs